SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending as community chatter intensifies around an upcoming futures launch, fueling speculative 'PUMP' and 'WAGMI' sentiment among holders. While some express frustration over its recent performance, many view current price levels as a significant accumulation opportunity within the broader meme coin ecosystem, anticipating a strong rebound.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending amidst active community discussion surrounding its resilience during broader crypto market dips, with many advocating for long-term holding and staking. A class-action lawsuit against the Solana-based platform pump.fun is a key talking point, yet enthusiasm remains high for its vibrant meme coin ecosystem and its potential as a leading Layer 1.

Apu, also known as Peepo or Helper, is a pepe-variant that is used to represent a much younger, kinder and more naive anthropomorphic frog. Fed up with low-effort memecoins, more often than not led by deceptive developers, Apu decided to create his own fairly launched, fully transparent coin: $APU – the one and only coin for all frens.

Apu Apustaja 

Apu Apustaja ($APU) is trending amid discussions of strong buying pressure and its recent listing on Hyperliquid, with the community actively highlighting its resilience. Enthusiastic investors view the "frenly frog" meme as a blue-chip asset with deep 4chan roots, anticipating significant growth in upcoming crypto cycles, especially within the Ethereum ecosystem. The vibrant community's long-term conviction is a key talking point, positioning APU for future appreciation alongside other established meme tokens.

KiboShib (KIBSHI) is the first AI-generated meme coin. On December 8th 2022, AI was tasked with creating a meme coin. It all started as a joke, but the idea which was proposed by the AI is so powerful that nobody could resist! The AI even suggested a logo design which later has been fed to the AI image generator. The age of AI is upon us, and KiboShib stands for exploring the capabilities of AI with a hopeful outlook.

KiboShib

KiboShib ($KIBSHI) is trending as the community champions its unique position as the "first AI-generated meme coin," combining two dominant crypto narratives. Enthusiasts are actively discussing its potential for substantial gains, frequently comparing it to the early stages of major meme tokens like $DOGE and $SHIB, given its low market capitalization and historical precedence within the emerging AI-driven market.

Kewaunee Scientific Corp. engages in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. It operates through the following segments: Domestic, International, and Corporate. The Domestic segment designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, casework, flexible systems, work surfaces, workstations, workbenches, and computer enclosures. The International segment offers products and services, including facility design, engineering, construction, and project management from the planning stage through testing and commissioning of laboratories. The company was founded in 1906 and is headquartered in Statesville, NC.

Kewaunee Scientific Corporation

Kewaunee Scientific is trending due to robust Q4 and FY25 results, with the Nu Aire acquisition driving significant sales and record earnings. While the market is reacting positively to the strong performance and favorable valuation multiples, community discussion also highlights ongoing executive share sales amidst the positive news. This surge reflects broader optimism for domestic manufacturing in the specialized lab equipment sector.

Bonk is a dog-themed memecoin on the Solana blockchain, launched on Christmas Day 2022 to revitalize the Solana community following the FTX collapse. Created by an anonymous team of 22 Solana developers and builders, Bonk distributed 50% of its total 100 trillion token supply via airdrop to community members including NFT collectors, developers, and artists.   The project positions itself as "the first Solana dog coin for the people, by the people," explicitly rejecting venture capital backing in favor of grassroots community ownership. What sets Bonk apart from other memecoins is its combination of fair launch mechanics, extensive ecosystem integration, and active deflationary strategy.   Built on Solana, BONK benefits from fast transaction speeds and low fees that make it practical for everyday use. Native products include LetsBonk.fun (a memecoin launchpad that briefly became Solana's market leader in 2025, surpassing Pump.fun with over 78% market share), BonkSwap (a decentralized exchange) and BonkBot (a Telegram trading bot with built-in burn mechanics).   BONK is available across 10 blockchain networks and listed on major exchanges including Binance, Coinbase, Kraken, and Robinhood. Governance is handled by BonkDAO, which holds 15% of the token supply and makes decisions through on-chain voting.   The community has organized several major burn events, most notably the December 2024 BURNmas campaign that destroyed 1.69 trillion tokens worth over $50 million. In September 2025, Nasdaq-listed Safety Shot, Inc. formed BONK Holdings LLC and acquired over 2.5% of the circulating supply (valued at $55-63 million), making BONK one of the first memecoins to attract formal corporate treasury adoption. Core contributor Nom was appointed to Safety Shot's board, and the company holds a 10% revenue share in LetsBonk.fun.  As with all memecoins, BONK is a highly speculative asset with substantial volatility. Its value is primarily driven by community sentiment, social media momentum, and meme culture rather than traditional utility.   The anonymous team, while common in the memecoin space, means investors should exercise appropriate caution. Despite these risks, Bonk has established itself as one of the most successful community-driven tokens in the Solana ecosystem, approaching 1 million unique holders and expanding from a simple memecoin into meaningful DeFi infrastructure.

BONK

BONK is trending due to significant developments, including the launch of its first ETP on the SIX Swiss Exchange and an eagerly anticipated 1 trillion token burn as the community nears 1 million holders. Community members are actively accumulating, anticipating a supply reduction and increased utility from features like its new zero-fee trading platform and Bonk Arena, which could drive a notable rally. This activity highlights BONK's evolving role within the Solana ecosystem, drawing interest despite recent market fluctuations.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is trending due to an oversubscribed $53 million private placement from leading healthcare institutional investors, which signals strong confidence in its lead candidate, FB102. This significant financing, combined with recent positive Phase 1b trial data for FB102 in celiac disease, has ignited discussions about the stock's low float and the potential for a substantial short squeeze.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is at the center of highly polarized community discussion, with many users expressing extreme bearishness and 

Clearwater Analytics Holdings, Inc. engages in the provision of web-based investment portfolio accounting, reporting, and reconciliation services. It operates through the United States and Rest of World geographical segments. Its products include automated data aggregation and validation, investment accounting, integrated reporting tools, a user-friendly solution, and business-specific tools. The company was founded in 2004 and is headquartered in Boise, ID.

Clearwater Analytics Holdings Inc - Ordinary Shares Class A

Clearwater Analytics is actively trending amid advanced takeover discussions involving multiple private equity firms like Permira, Warburg Pincus, and Thoma Bravo, further fueled by an activist stake from Starboard Value urging a sale process. The community is debating potential buyout valuations, with many anticipating offers in the high $20s to low $30s per share, while others believe management should resist a sale due to the company's strong growth and positioning as an "institutional AI powerhouse." This M&A interest is driving significant market conversation and technical analysis, with many eyes on a potential breakout.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap is trending due to an active governance proposal, "UNIfication," which seeks to activate a protocol fee switch and introduce a significant token burn mechanism. The community is buzzing with optimism that these changes will enhance UNI's value by directly benefiting token holders and reducing the circulating supply, solidifying its position as a DeFi blue chip.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Spero Therapeutics (NASDAQ:SPRO) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen raised Spero Therapeutics from a "hold" rating to a "buy" rating in a research report on Sunday...

Spero Therapeutics (NASDAQ:SPRO) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded Spero Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...

Wall Street Zen raised Spero Therapeutics from a "hold" rating to a "buy" rating in a research note on Friday...

Spero Therapeutics (NASDAQ:SPRO) Shares Pass Above 200 Day Moving Average on Insider Selling

Spero Therapeutics (NASDAQ:SPRO) Shares Cross Above Two Hundred Day Moving Average After Insider Selling...

Spero Therapeutics (NASDAQ:SPRO) Issues Earnings Results, Beats Estimates By $0.12 EPS

Spero Therapeutics (NASDAQ:SPRO - Get Free Report) announced its earnings results on Thursday. The company reported ($0.13) EPS for the quarter, topping analysts' consensus estimates of ($0.25) by...

Spero Therapeutics (NASDAQ:SPRO) Insider Esther Rajavelu Sells 40,270 Shares

Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) insider Esther Rajavelu sold 40,270 shares of the stock in a transaction on Friday, November 7th. The shares were sold at an average price of...

Spero Therapeutics (NASDAQ:SPRO) Insider Sells $95,439.90 in Stock

Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) insider Esther Rajavelu sold 40,270 shares of the business's stock in a transaction that occurred on Friday, November 7th. The stock was sold...

Best Momentum Stock to Buy for October 10th

SPRO made it to the Zacks Rank #1 (Strong Buy) momentum stock list on October 10, 2025.

Bayer Reports Positive Data on Cell Therapy for Parkinson's Disease 

BAYRY's subsidiary BlueRock reports 36-month data showing its Parkinson's therapy bemdaneprocel remains safe and effective in easing motor symptoms.

Down 17.7% in 4 Weeks, Here's Why Spero Therapeutics (SPRO) Looks Ripe for a Turnaround 

The heavy selling pressure might have exhausted for Spero Therapeutics (SPRO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.

Current Price	$2.32
Prev Close	$2.29
Open	$2.35
Dividend Yield	0.00%
50-Day Moving Average	$2.35
Beta	0.85
Avg. Volume	494,873.16
PE Ratio	-2.92

52-Week High	$3.22
52-Week Low	$0.5052
Market Capitalization	$130.71M
EPS (Annual)	-$1.27
Price to Book	4.93
Revenue Per Employee	$856,125.00
Enterprise Value/EBITDA	N/A

SPRO
Spero Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SPRO News

SPROSpero Therapeutics Inc